SIP 1.55% $1.31 sigma pharmaceuticals limited

Feb 17 (Reuters) - Sigma Pharmaceuticals Ltd (SIP) : Advise...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Feb 17 (Reuters) - Sigma Pharmaceuticals Ltd (SIP) :

    • Advise that underlying ebit is expected to be just over $100 million for fy
    • Fy reported ebit is however expected to be broadly in line with last year
    • Sigma pharmaceuticals ltd - "remain comfortable with our existing guidance of at least 5% underlying ebit growth for 2017/18 financial year"
    • Sigma pharmaceuticals - new guidance for full year compares with previous guidance of 10% underlying ebit growth
 
watchlist Created with Sketch. Add SIP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.